← Leaderboards
Michael Ohliger
University Of California, San Francisco
$3,943,738
Attributed
$8,889,670
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,889,670 · 5
By mechanism
R01$8,453,795 · 4
R21$435,875 · 1
Top collaborators
- David M Wilson10 shared
- Cornelius Von Morze5 shared
- Joanne N. Engel4 shared
- Oren S Rosenberg3 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- David M Wilson$11,449,852
- Jae Woo Lee$6,294,028
- Zhen Jane Wang$4,501,373
- Cornelius Von Morze$2,503,783
- Joanne N. Engel$29,989,228
Others in their field
Other Emerging Leaders on “Clinical Translation”
- Leonard Freedman · Leidos Biomedical Research, Inc.$362,430,297
- Lynn Briscoe · Leidos Biomedical Research, Inc.$130,241,827
- Leonard Freedmand · Leidos Biomedical Research, Inc.$95,252,769
- Bambra Strokes · Ppd Development Lp$65,000,267
- Klaus Romero · Critical Path Institute$56,862,776
- Prasant Mohapatra · University Of California At Davis$51,504,377
Research focus
Clinical TranslationDiagnosisImageMetabolicImaging TechniquesMetabolic ImagingImaging TechnologyImaging ModalityResponseBaseIn VivoRattusBacteriaPre-Clinical ModelRadiotracerTracerAntibiotic TherapyDetectionPerformanceInfectionIn VitroAcutePositron-Emission TomographyUptake
Grant awards (17)
Chemoenzymatic radiosyntheses of [18F]FDG-derived oligosaccharides for S. aureus detection$739,895
R01 · FY2025 · AI
Chemoenzymatic radiosyntheses of [18F]FDG-derived oligosaccharides for S. aureus detection$780,034
R01 · FY2024 · AI
Sensing living P. aeruginosa using D-alanine derived radiotracers$663,113
R01 · FY2024 · EB
Sensing living P. aeruginosa using D-alanine derived radiotracers$676,646
R01 · FY2023 · EB
Sensing living P. aeruginosa using D-alanine derived radiotracers$676,646
R01 · FY2022 · EB
Novel hyperpolarized 13C molecular imaging techniques for differentiating NAFLD and NASH$415,502
R01 · FY2022 · DK · contact PI
Sensing living P. aeruginosa using D-alanine derived radiotracers$676,646
R01 · FY2021 · EB
Novel hyperpolarized 13C molecular imaging techniques for differentiating NAFLD and NASH$415,502
R01 · FY2021 · DK · contact PI
Clinical translation of D-amino acid derived PET tracers for imaging spinalinfection$540,182
R01 · FY2020 · EB
Novel hyperpolarized 13C molecular imaging techniques for differentiating NAFLD and NASH$415,817
R01 · FY2020 · DK · contact PI
Clinical translation of D-amino acid derived PET tracers for imaging spinalinfection$506,483
R01 · FY2019 · EB
Novel hyperpolarized 13C molecular imaging techniques for differentiating NAFLD and NASH$416,246
R01 · FY2019 · DK · contact PI
Clinical translation of D-amino acid derived PET tracers for imaging spinalinfection$555,554
R01 · FY2018 · EB
Novel hyperpolarized 13C molecular imaging techniques for differentiating NAFLD and NASH$416,408
R01 · FY2018 · DK · contact PI
Exploring combined hyperpolarized 13C MRI with liver-specific gadolinium contrast agents for improved metabolic assessment of liver tumors$198,125
R21 · FY2018 · EB · contact PI
Clinical translation of D-amino acid derived PET tracers for imaging spinalinfection$559,121
R01 · FY2017 · EB
Exploring combined hyperpolarized 13C MRI with liver-specific gadolinium contrast agents for improved metabolic assessment of liver tumors$237,750
R21 · FY2017 · EB · contact PI